Post Closing Registration. Company currently has on file with the SEC form SB-2. Prior to the effective date of the SB-2, the SB-2 shall be amended to provide that the Shares, and each of them, shall be registered in such filing. While acting in a commercially reasonable fashion, Company shall, either upon receipt of comments from the SEC or, in the event that no comments are to be received on the SB-2 from the SEC, then prior to the Effective Date, amend the SB-2 to indicate that up to 781,250 of the Shares are owned beneficially and of record by ▇▇▇▇▇▇, which is the Selling Shareholder of such shares.
Appears in 2 contracts
Sources: Convertible Debenture (Iq Biometrix Inc), Convertible Debenture (Iq Biometrix Inc)
Post Closing Registration. Company currently has on file with the SEC form SB-2. Prior to the effective date of the SB-2, the SB-2 shall be amended to provide that the Shares, and each of them, shall be registered in such filing. While acting in a commercially reasonable fashion, Company shall, either upon receipt of comments from the SEC or, in the event that no comments are to be received on the SB-2 from the SEC, then prior to the Effective Date, amend the SB-2 to indicate that up to 781,250 of the Shares are owned beneficially and of record by ▇H▇▇▇▇▇, which is the Selling Shareholder of such shares.
Appears in 1 contract
Post Closing Registration. Company currently has on file with the SEC form SB-2. Prior to the effective date of the SB-2, the SB-2 shall be amended to provide that the Shares, and each of them, shall be registered in such filing. While acting in a commercially reasonable fashion, Company shall, either upon receipt of comments from the SEC or, in the event that no comments are to be received on the SB-2 from the SEC, then prior to the Effective Date, amend the SB-2 to indicate that up to 781,250 of the Shares are owned beneficially and of record by Holder, whic▇ ▇▇ ▇▇▇▇▇, which is the he Selling Shareholder of such shares.
Appears in 1 contract